➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Dow
Johnson and Johnson
AstraZeneca
Colorcon

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

Pentetate calcium trisodium - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for pentetate calcium trisodium and what is the scope of patent protection?

Pentetate calcium trisodium is the generic ingredient in two branded drugs marketed by Hameln Pharma Plus and 3M, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for pentetate calcium trisodium. One supplier is listed for this compound.

Summary for pentetate calcium trisodium
Recent Clinical Trials for pentetate calcium trisodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 1/Phase 2

See all pentetate calcium trisodium clinical trials

Pharmacology for pentetate calcium trisodium
Drug ClassLead Chelator
Mechanism of ActionLead Chelating Activity

US Patents and Regulatory Information for pentetate calcium trisodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hameln Pharma Plus PENTETATE CALCIUM TRISODIUM pentetate calcium trisodium SOLUTION;INHALATION, INTRAVENOUS 021749-001 Aug 11, 2004 RX Yes Yes   Start Trial   Start Trial   Start Trial
3m YTTERBIUM YB 169 DTPA pentetate calcium trisodium yb-169 INJECTABLE;INJECTION 017518-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Medtronic
Johnson and Johnson
AstraZeneca
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.